Rare lephants
Screener

Neogen Corporation

NEOG ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Oct 23, 2026 PRIMARY DOCUMENT
3 Oct 23, 2026 PRIMARY DOCUMENT
3 Oct 21, 2026 PRIMARY DOCUMENT
3 Oct 21, 2026 PRIMARY DOCUMENT
3 Oct 21, 2026 PRIMARY DOCUMENT
S-8 Oct 20, 2026 S-8
S-8 Oct 20, 2026 S-8
4 Oct 9, 2026 PRIMARY DOCUMENT
10-Q Oct 7, 2026 10-Q
8-K Oct 7, 2026 8-K
8-K Oct 6, 2026 8-K
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
4 Oct 2, 2026 PRIMARY DOCUMENT
DEFA14A Sep 28, 2026 DEFA14A
ARS Aug 21, 2026 ARS
DEFA14A Aug 21, 2026 DEFA14A
DEF 14A Aug 21, 2026 DEF 14A
4 Aug 20, 2026 PRIMARY DOCUMENT
4 Aug 20, 2026 PRIMARY DOCUMENT
← Newer Page 1 of 76 · 1896 filings Older →